Compare Cigna Corp (CI) vs Microsoft (MSFT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Microsoft — how do they compare? Cigna Corp trades at $298.41 (market cap $80.25B), while Microsoft trades at $387 (market cap $2.86T). The key difference: Microsoft is far larger — about 35.6× Cigna Corp's market cap, and Cigna Corp pays the higher dividend (2.06%). Which is the better fit depends on your goals.
| CI | MSFT | |
|---|---|---|
Market Cap | $80.25B | $2.86T |
Sector | Health | Technology |
52-Week High | $311.00 | $542.07 |
52-Week Low | $244.41 | $352.83 |
Enterprise Value | $103.35B | $2.84T |
Dividend Yield | 2.06% | 0.95% |
Volume | — | 36,654,621 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $304.50, up 3.76% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $7.79 exceeding the $7.60 estimate. Valuation metrics appear attractive with a P/E of 12.91 and P/S of 0.29. Recent news highlights strategic AI investments in pharmacy services and positive sector sentiment.
The investment case centers on undervaluation, earnings momentum, and dividend yield, though risks include regulatory challenges and moderating cash flow. With a consensus price target of $339.82 implying 11.6% upside, Wall Street maintains a bullish stance, but investors should weigh execution risks against growth initiatives.
Microsoft (MSFT) trades at $387.66, down 0.85% with a bearish technical signal. The company demonstrates strong fundamentals with Q1 2026 EPS of $4.27 beating expectations of $4.06, continuing a trend of earnings beats. Revenue grew to $281.72B in 2025 with a robust 39.34% net income margin. Analyst consensus remains overwhelmingly bullish with 80.49% buy ratings and a $551.62 price target, representing 42% upside potential from current levels.
Microsoft's AI leadership and cloud computing strength provide significant growth catalysts, though increased capital expenditures and competitive pressures present near-term challenges. The stock's current valuation at 22.93 P/E appears reasonable given consistent earnings growth and strong cash flow generation, making it attractive for long-term investors despite technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Microsoft
Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.
Read more on MSFT →
